AbCellera BiologicsABCL

那斯達克 · USD
4.24
-0.24
(-5.26%)
盤中 08/02 03:48 (UTC+8)
08/02 03:48 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.22
  • 0.12
  • 0.10
  • 0.07
  • 0.09
  • 0.10
  • 0.07
  • 0.07
  • 0.05
  • 0.04
icon
  • -78.75
  • -43.41
  • -17.52
  • -34.39
  • 39.12
  • 8.44
  • -26.43
  • -11.16
  • -22.38
  • -16.14
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
4,235
5,050
6,506
7,323
9,954
9,179
6,598
10,056
12,192
21,545
營業成本
----------
營業毛利
4,235
5,050
6,506
7,323
9,954
9,179
6,598
10,056
12,192
21,545
營業費用
66,895-100,169100,777-75,23261,48961,44577,06659,323
研發費用
42,49646,07640,96940,92739,28748,62237,91636,47352,64728,245
推銷及管理費用
19,06819,16422,28123,32820,71719,07417,83819,36218,90515,706
非經常性項目費用
---------1,554
其他營業費用
5,33112,56536,91936,5224,8447,5365,7355,6105,51413,818
營業利益
-62,660
-72,755
-93,663
-93,454
-54,894
-66,053
-54,891
-51,389
-64,874
-37,778
其他收入及費用
9,67625,92631,03145,26712,14717,45115,61513,38616,72610,411
利息費用
---------4,045
稅前純益
-52,984
-46,829
-62,632
-48,187
-42,747
-48,602
-39,276
-38,003
-48,148
-31,412
所得稅
-7,363-12,619-11,525-11,257-2,137-1,452-10,666-7,475-8,038-1,519
稅後純益
-45,621
-34,210
-51,107
-36,930
-40,610
-47,150
-28,610
-30,528
-40,110
-29,893
基本每股稅後盈餘(元)
-0.15-0.11-0.17-0.13-0.14--0.10-0.11-0.14-0.10
稀釋每股稅後盈餘(元)
-0.15-0.11-0.18-0.12-0.14-0.17-0.10-0.10-0.14-0.10
基本平均股數(千股)
297692.00295519.00294851.00294217.00292723.00-289496.00288905.00287767.00286307.00
稀釋平均股數(千股)
297692.00295519.00294851.00294217.00292723.00-289496.00288905.00287767.00316757.00
還原基本每股稅後盈餘(元)
-0.15-0.11-0.17-0.13-0.14--0.10-0.11-0.14-0.10
還原稀釋每股稅後盈餘(元)
-0.15-0.11-0.18-0.12-0.14-0.17-0.10-0.10-0.14-0.10
還原基本平均股數(千股)
297,692295,519294,851294,217292,723-289,496288,905287,767286,307
還原稀釋平均股數(千股)
297,692295,519294,851294,217292,723-289,496288,905287,767316,757
EBITDA(千元)
-46,379-32,929-24,337-10,150-35,981-39,493-31,867-30,747-41,028-12,007

大家都在看

HOT